Schizophrenia research and treatment
Schizophrenia research and treatment is a research topic within Psychiatry and Mental health. Science Explorer counts 58k research works in it since 1950. 23.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the research, treatment, and various aspects of schizophrenia, including the effectiveness of antipsychotic drugs, neurocognitive deficits, genetic association studies, metabolic syndrome, neurodevelopmental models, cognitive therapy, social cognition, prodromal symptoms, dopamine dysfunction, and neuroanatomical abnormalities in individuals with schizophrenia.
- Antipsychotic Drugs
- Neurocognitive Deficits
- Genetic Association Studies
- Metabolic Syndrome
- Neurodevelopmental Model
- Cognitive Therapy
- Social Cognition
- Prodromal Symptoms
- Dopamine Dysfunction
- Neuroanatomical Abnormalities
- Research works
- 58k fractional, since 1950
- In the world top 10%
- 13k per year above
- Top-10% rate
- 23.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +4% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Schizophrenia research and treatment research?
By volume, the United States and the United Kingdom publish the most (1.8k and 769 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.8k works
- 2 United Kingdom 769 works
- 3 China 697 works
- 4 Spain 399 works
- 5 Canada 375 works
- 6 Germany 357 works
- 7 Australia 323 works
- 8 India 314 works
- 9 Italy 304 works
- 10 Japan 241 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Schizophrenia research and treatment research?
By volume in 2022–2025, King's College London publishes the most Schizophrenia research and treatment research, followed by University of North Carolina at Chapel Hill and Harvard University.
By volume, 2022–2025
- 1 King's College LondonUnited Kingdom 72 works
- 2 University of North Carolina at Chapel HillUnited States 69 works
- 3 Harvard UniversityUnited States 41 works
- 4 University College LondonUnited Kingdom 37 works
- 5 University of TorontoCanada 37 works
- 6 Yale UniversityUnited States 35 works
- 7 National Institute of Mental Health and NeurosciencesIndia 33 works
- 8 South London and Maudsley NHS Foundation TrustUnited Kingdom 31 works
- 9 Centre for Addiction and Mental HealthCanada 30 works
- 10 Centro de Investigación Biomédica en Red de Salud MentalSpain 28 works
Who are the leading researchers in Schizophrenia research and treatment?
The most-cited researchers publishing on Schizophrenia research and treatment include Julie Glanville, Theo Vos and Ronald C. Kessler.
- 1 Julie Glanville United Kingdom 13k citations
- 2 Theo Vos United States 12k citations
- 3 Ronald C. Kessler United States 9.8k citations
- 4 Dan J. Stein South Africa 7.7k citations
- 5 Josep María Haro Spain 6.4k citations
- 6 Louisa Degenhardt Australia 5.7k citations
- 7 John J. McGrath Australia 5.3k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Schizophrenia research and treatment research done?
The largest centres of Schizophrenia research and treatment research in 2022–2025 are London (United Kingdom), New York (United States), Beijing (China) and Toronto (Canada).
Largest cities, 2022–2025
Where is the best place to study Schizophrenia research and treatment?
Among universities, judged by research, King's College London, University of Campania "Luigi Vanvitelli" and Donald & Barbara Zucker School of Medicine at Hofstra/Northwell score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | King's College LondonUnited Kingdom | 73.6 | 30.3% | 12.2× | 72 | -5.9% |
| 2 | University of Campania "Luigi Vanvitelli"Italy | 59.4 | 22.1% | 8.7× | 14 | +524.4% |
| 3 | Donald & Barbara Zucker School of Medicine at Hofstra/NorthwellUnited States | 59.2 | 34.6% | 30.9× | 10 | — |
| 4 | Karolinska InstitutetSweden | 57.6 | 31.2% | 6.3× | 22 | +12.6% |
| 5 | University of CopenhagenDenmark | 55.5 | 30.8% | 5.0× | 27 | +42.0% |
| 6 | University College LondonUnited Kingdom | 54.4 | 31.1% | 3.5× | 38 | +37.6% |
| 7 | Temple UniversityUnited States | 48.7 | 42.3% | 4.5× | 9 | +39.3% |
| 8 | Harvard UniversityUnited States | 48.5 | 25.4% | 4.2× | 41 | -19.1% |
| 9 | Cardiff UniversityUnited Kingdom | 46.6 | 40.4% | 3.7× | 12 | -16.6% |
| 10 | University of GeorgiaUnited States | 46.5 | 22.8% | 3.9× | 14 | +245.1% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Schizophrenia research and treatment research growing?
Output in 2018–2022 was 4% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Schizophrenia research and treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.